Glenn A. MEYER,Cristian R. FRANCO,Gustavo A. FISCHBEIN,Alejandro A. AGUILAR,Claude E. WRIGHT
申请号：
US16798652
公开号：
US20200188341A1
申请日:
2020.02.24
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
